Köln verbietet Verkauf von CBD-Produkten als Lebensmittel. In: Deutsche Apothekerzeitung. 23. Juni 2020 (deutsche-apotheker-zeitung.de).
doi.org
Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarães FS (December 2012). "Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences (Review). 367 (1607): 3364–78. doi:10.1098/rstb.2011.0389. PMC 3481531 (freier Volltext). PMID 23108553.
A. W. Zuardiet al.: Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. In: Braz. J. Med. Biol. Res. (Review) 39 (4), April 2006, S. 421–429. doi:10.1590/S0100-879X2006000400001. PMID 16612464.
P. Flachenecker: A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany. In: Expert Review of Neurotherapeutics. Band 13, Nummer 3 Suppl 1, Februar 2013, S. 15–19, doi:10.1586/ern.13.1. PMID 23369055.
G. Esposito et al.: Cannabidiol in inflammatory bowel diseases: a brief overview. In: Phytotherapy research : PTR. Band 27, Nummer 5, Mai 2013, S. 633–636, doi:10.1002/ptr.4781. PMID 22815234.
V. Micale et al.: Endocannabinoid system and mood disorders: priming a target for new therapies. In: Pharmacology & therapeutics. Band 138, Nummer 1, April 2013, S. 18–37, doi:10.1016/j.pharmthera.2012.12.002. PMID 23261685.
Andrew Moore, Sebastian Straube, Emma Fisher, Christopher Eccleston: Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms. In: The Journal of Pain. Band25, Nr.4, April 2024, S.833–842, doi:10.1016/j.jpain.2023.10.009.
Dixon H. Xu et al.: The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities. In: Current Pharmaceutical Biotechnology. 1. Dezember 2019, doi:10.2174/1389201020666191202111534, PMID 31793418.
D.C. Hammell et al.: Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. In: European journal of pain (London, England). Band20, Nr.6, Juli 2016, S.936–948, doi:10.1002/ejp.818, PMID 26517407, PMC 4851925 (freier Volltext) – (englisch).
Penny F. Whiting, Robert F. Wolff, Sohan Deshpande, Marcello Di Nisio, Steven Duffy: Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. In: JAMA. Band313, Nr.24, Juni 2015, S.2456–2473, doi:10.1001/jama.2015.6358, PMID 26103030.
A. Huestis Marilyn, Solimini Renata, Pichini Simona, Pacifici Roberta, Carlier Jeremy: Cannabidiol Adverse Effects and Toxicity. 30. September 2019, abgerufen am 29. Juli 2021 (englisch).
Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarães FS (December 2012). "Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences (Review). 367 (1607): 3364–78. doi:10.1098/rstb.2011.0389. PMC 3481531 (freier Volltext). PMID 23108553.
A. W. Zuardiet al.: Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. In: Braz. J. Med. Biol. Res. (Review) 39 (4), April 2006, S. 421–429. doi:10.1590/S0100-879X2006000400001. PMID 16612464.
Sadiye Amcaoglu Riederet al.: Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. In: Immunobiology. Band215, Nr.8, August 2010, PMID 19457575.
Saphala Dhital et al.: Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation. In: Cellular Immunology. Band312, 2017, PMID 27865421.
Andrenyak DM, Moody DE, Slawson MH, O’Leary DS, Haney M: Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry., J Anal Toxicol. 2017 May 1;41(4):277-288, PMID 28069869
Pigliasco F, Barco S, Dubois S, Marchese F, Striano P, Lomonaco T, Mattioli F, Tripodi G, Cangemi G: Cannabidiol Determination on Peripheral Capillary Blood Using a Microsampling Method and Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry with On-Line Sample Preparation. Molecules. 2020 Aug 8;25(16):3608, PMID 32784413
Cliburn KD, Huestis MA, Wagner JR, Kemp PM: Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry., J Chromatogr A. 2021 Aug 30;1652:462345, PMID 34198104
Cobo-Golpe M, de-Castro-Ríos A, Cruz A, López-Rivadulla M, Lendoiro E: Determination and Distribution of Cannabinoids in Nail and Hair Samples. J Anal Toxicol. 2021 Nov 9;45(9):969-97, PMID 33064813
Ramnarine RS, Poklis JL, Wolf CE: Determination of Cannabinoids in Breast Milk Using QuEChERS and Ultra-Performance Liquid Chromatography and Tandem Mass Spectrometry., J Anal Toxicol. 2019 Oct 17;43(9):746-752, PMID 31436289
P. Flachenecker: A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany. In: Expert Review of Neurotherapeutics. Band 13, Nummer 3 Suppl 1, Februar 2013, S. 15–19, doi:10.1586/ern.13.1. PMID 23369055.
G. Esposito et al.: Cannabidiol in inflammatory bowel diseases: a brief overview. In: Phytotherapy research : PTR. Band 27, Nummer 5, Mai 2013, S. 633–636, doi:10.1002/ptr.4781. PMID 22815234.
V. Micale et al.: Endocannabinoid system and mood disorders: priming a target for new therapies. In: Pharmacology & therapeutics. Band 138, Nummer 1, April 2013, S. 18–37, doi:10.1016/j.pharmthera.2012.12.002. PMID 23261685.
D. Hermann und M. Schneider: Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review. In: Curr Pharm Des. 18(32), 2012, S. 4897–4905. Review. PMID 22716143.
Dixon H. Xu et al.: The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities. In: Current Pharmaceutical Biotechnology. 1. Dezember 2019, doi:10.2174/1389201020666191202111534, PMID 31793418.
D.C. Hammell et al.: Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. In: European journal of pain (London, England). Band20, Nr.6, Juli 2016, S.936–948, doi:10.1002/ejp.818, PMID 26517407, PMC 4851925 (freier Volltext) – (englisch).
Penny F. Whiting, Robert F. Wolff, Sohan Deshpande, Marcello Di Nisio, Steven Duffy: Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. In: JAMA. Band313, Nr.24, Juni 2015, S.2456–2473, doi:10.1001/jama.2015.6358, PMID 26103030.
Sarah Heuberger: Neues BGH-Urteil zu Cannabisblüten ist für Start-ups nur ein Teilerfolg. In: DIE WELT. 31. März 2021 (welt.de [abgerufen am 10. September 2021]).
Till Uebelacker: CBD-Produkte: Verbraucherschützer warnen vor Nebenwirkungen. In: DIE WELT. 21. Dezember 2020 (welt.de [abgerufen am 29. Juli 2021]).
zeit.de
Kiffen für Streber. In: Die Zeit. 22. Mai 2019 (zeit.de).